Hypertension Diagnostics, Inc.
HDII
Rank in Stocks
#34166
Hypertension Diagnostics, Inc. (HDII) is a company that designs, develops,... Hypertension Diagnostics, Inc. (HDII) is a company that designs, develops, manufactures, and commercializes its own innovative, non-invasive medical technologies. These devices are engineered to identify minute changes in the flexibility of arteries, serving both domestic and international markets. Central to their offerings is the CVProfilor, a system designed for non-invasive assessment of both large and small artery elasticity. The elasticity of small arteries is especially critical, serving as the earliest and most sensitive indicator of cardiovascular disease. The product suite includes the CVProfilor DO-2020, which delivers essential arterial elasticity indices, aiding in the diagnosis of underlying vascular conditions. Its counterpart, the CVProfilor MD-3000, offers precise and specific insights into the presence of blood vessel disease. For scientific study, the HD/PulseWave CR-2000 is a specialized cardiovascular profiling system, equipping scientists and investigators with a non-intrusive method to evaluate arterial elasticity across diverse human research domains. These devices operate by capturing 30 seconds of blood pressure waveform data, subsequently analyzing the digitized patterns to generate a comprehensive CVProfile report. This report details crucial metrics including blood pressure, heart rate, pulse pressure, body surface area, body mass index, and indices for both C1 (large) and C2 (small) artery elasticity. HDII caters to a broad spectrum of clients, including general practitioners, cardiologists, various healthcare practitioners, skilled medical staff, academic and government research scientists, cardiovascular specialists, and pharmaceutical companies. In the U.S., sales are facilitated by a dedicated network of representatives. Established in 1988, Hypertension Diagnostics, Inc. maintains its headquarters in Richmond Hill, Canada.
Share Price
$0.0001
Last synced: 2026-11-13
Market Cap
$28.48K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Hypertension Diagnostics, Inc. (HDII)
Category
Financial Services
Operating Margin for Hypertension Diagnostics, Inc. (HDII)
Operating Margin as of November 2026 TTM: 0.00%
According to Hypertension Diagnostics, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2021 the company had an operating margin of 0.00%.
Operating Margin history for Hypertension Diagnostics, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | -100.00% |
| 2018 | -4.25% | -61.22% |
| 2017 | -10.96% | -40.40% |
| 2016 | -18.39% | -57.30% |
| 2012 | -43.07% | 63.45% |
| 2011 | -26.35% | -63.49% |
| 2010 | -72.18% | 38.62% |
| 2009 | -52.07% | -61.51% |
| 2008 | -135.27% | 346.73% |
| 2007 | -30.28% | -58.94% |
| 2006 | -73.74% | -41.43% |
| 2005 | -125.89% | -25.64% |
| 2004 | -169.30% | -48.96% |
| 2003 | -331.73% | -69.59% |
| 2002 | -1,090.86% | 807.69% |
| 2001 | -120.18% | -86.01% |
| 2000 | -859.05% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 0.00% | - |
US
|
|
| 9.21% | - |
US
|
|
| -2,061.14% | - |
CN
|
|
| 2.14% | - |
US
|
|
| -8,210.71% | - |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Hypertension Diagnostics, Inc.'s operating margin
What was Hypertension Diagnostics, Inc.'s operating margin in 2021?
In 2021, Hypertension Diagnostics, Inc.'s operating margin was 0.00%, compared with 0.00% in 2020.
How has Hypertension Diagnostics, Inc.'s operating margin changed since 2016?
From 2016 to 2021, Hypertension Diagnostics, Inc.'s operating margin was highest in 2021 (0.00%) and lowest in 2016 (-18.39%).
How does Hypertension Diagnostics, Inc.'s operating margin compare with similar companies?
Hypertension Diagnostics, Inc.'s operating margin (0.00%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Worldwide Webb Acquisition Corp., with 9.21%.